MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/bjh.20208

Медицинская библиотека · British journal of haematology · 2025

Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013-2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy.

Konuma Takaaki, Shimomura Yoshimitsu, Mizuno Shohei, Yamasaki Satoshi, Yui Shunsuke, Uchida Naoyuki, Doki Noriko, Tanaka Masatsugu, Yoshihara Satoshi, Eto Tetsuya, Katayama Yuta, Katsuoka Yuna, Tokunaga Masahito, Ota Shuichi, Sakata-Yanagimoto Mamiko, Ishiwata Kazuya, Kanda Yoshinobu, Kawakita Toshiro, Onizuka Makoto, Kanda Junya, Fukuda Takahiro, Atsuta Yoshiko, Yanada Masamitsu

СтатьяПеревод пока не подготовлен

Аннотация

Primary refractory acute myeloid leukaemia (AML) remains a major clinical challenge, with poor outcomes despite salvage chemotherapy. Allogeneic haematopoietic cell transplantation (HCT) continues to be a potentially curative option for these patients. However, recent data on outcomes and prognostic factors specific to primary refractory AML remain limited. We conducted a retrospective analysis of 2600 adult patients with primary refractory AML who underwent their first allogeneic HCT between 2013 and 2022, using data from the Japanese national registry. The 3-year overall survival (OS) and leukaemia-free survival (LFS) rates were 28.5% and 24.4% respectively. The multivariate analysis identified older age (≥50 years), poor performance status (≥2), adverse cytogenetics, extramedullary disease at diagnosis and higher peripheral blood blast count at HCT (≥10%) as significant risk factors for worse OS and LFS. The cumulative incidences of relapse and non-relapse mortality at 3 years were 49.8% and 25.8% respectively. Based on the five significant risk factors, we developed a scoring system that effectively stratified patients into distinct prognostic groups for OS and LFS. This nationwide analysis demonstrated that allogeneic HCT offers the potential for long-term survival in adult patients with primary refractory AML. The proposed risk-scoring system may support clinical decision-making and patient counselling.

Для цитирования: Konuma Takaaki, Shimomura Yoshimitsu, Mizuno Shohei, Yamasaki Satoshi, Yui Shunsuke, Uchida Naoyuki, Doki Noriko, Tanaka Masatsugu, Yoshihara Satoshi, Eto Tetsuya, Katayama Yuta, Katsuoka Yuna, Tokunaga Masahito, Ota Shuichi, Sakata-Yanagimoto Mamiko, Ishiwata Kazuya, Kanda Yoshinobu, Kawakita Toshiro, Onizuka Makoto, Kanda Junya, Fukuda Takahiro, Atsuta Yoshiko, Yanada Masamitsu. Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013-2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy.. British journal of haematology. 2025. DOI: 10.1111/bjh.20208.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.